Halozyme Therapeutics Inc (HALO)

[Fred Kadiddlehopper]

I don't put a lot of stock in death crosses, they just show a trend that has been obvious for a while, so while the two lines are converging, I think we all know why. The question is what price the company's cash flows can support and I do think it can get back to the mid-50's by year's end, absent any nasty surprises or ham handed moves by Helen & Co.
Also, the drop in the 10 year bonds has re-established the value of HALO stock as a quasi-divi play with 2% return as my guide. That was a really accurate metric until the refi bungle and the bond market turbulence. Both of those things are in the rearview mirror, for now at least.
-Fritz